actively trading these days
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We just can't seem to break .05. But we will.
More action this morning. At some point, this should explode. Only about 80M shares O/S.
Yep. All I need.
Judas Priest, we have an hour long CC every quarter. What do you people want? Hand holding?
That is what I am saying. IMO, there is no way they will NOT file, given what they did last year.
CZNI caught up with all their back filings last year. In 15 years of trading OTC stocks, I have never ever seen an OTC/pink company pull that off. They did not go to all that effort and expense just to let the most recent filing lapse. That was done to make this empty shell valuable, and we will see that payoff.
No it doesn't. Believe me, I am in this deep, but I get tired of hearing every day how this is going to pop any minute. It just makes this play sound less reliable than it probably is.
I've been hearing about the imminence for 8-10 months. None of us knows when.
Of the 15 stocks I either own or follow, CZNI is the only one in the green.
OK. I had to add some at these prices.
There has been strength here for a couple of weeks. Someone wants this stock.
P.S. I have emailed Jeff Margolis several times over the past year, and I always get a prompt reply back.
OK. Time to move up in preparation for a real move next week. Too close to license approval for investors not to notice.
I added today. Totally safe at this pps, IMO.
This one trades in a different way than most, probably because of the very small O/S. But, I own a ton of this.
Gapping up this morning, possibly due to the upgrade by Jefferies.
Can you post the link?
We all have a story like that to tell. I'm sorry for your loss. LOL.
This is a typical Friday before a 3-day weekend. Low volume and sinking prices generally. And I assume you know that there is a cadre of traders who never hold a position through any weekend. This is why Friday is a buying day, not a selling day, for the rest of us.
My average is lower than yours with 1M shares, but you should be just fine.
This volume is amazing. 5M already.
General question. OTC stocks are booming everywhere all of a sudden. I have one up 40%, another up 80%, and another up 160% just today. They started going up days ago. Anyone have an idea of what is happening?
Same for me, but now I am happily green.
Holy pot smoke Batman. This thing is smokin.
I thought this was supposed to disappear because they filed Chapter 7. Someone please explain.
Not sure why at this time, but ELTP is showing some real bid strength lately.
Analyst Actions: HC Wainwright Adjusts Price Target on AzurRx BioPharma to $3.50 From $2, Reiterates Buy Rating
BY MT Newswires
— 7:56 AM ET 02/10/2021
07:56 AM EST, 02/10/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 1.9400, Change: +0.12, Percent Change: +6.59
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
I hope you are correct. This is my second time around with this stock in the last month.
We are at the HOD at 3:30 = very bullish for tomorrow.
New 52-week high hit today!!
NEWS!
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections
BY GlobeNewswire
— 6:30 AM ET 02/09/2021
Phase 2 Study of oral niclosamide planned for 1H 2021
DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ( AZRX) , (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that it has entered into an agreement with PPD, Inc. , a leading global contract research organization (CRO), for its planned Phase 2 clinical trial evaluating a proprietary formulation of micronized niclosamide as a treatment for COVID-19-associated gastrointestinal (GI) infections.
Under the terms of the agreement, PPD will manage the Phase 2 clinical trial for an immediate-release capsule formulation of micronized oral niclosamide, also known as FW-1022. Licensed by AzurRx in January from FirstWave Bio, Inc., the goal of AzurRx’s FW-1022 clinical program is to develop a safe, effective, non-systemic treatment for GI infections related to COVID-19. AzurRx anticipates initiating the trial in the first half of 2021.
“We are moving rapidly to initiate the planned Phase 2 trial of FW-1022 and are pleased to have PPD as our CRO partner given the company’s proven expertise and track record of clinical excellence,” said James Sapirstein, President and CEO of AzurRx BioPharma ( AZRX). “Even as the vaccine rollout continues, millions of people will become infected with the SARS-CoV-2 virus, and recent study data suggest approximately 1 in 5 of those stricken will suffer COVID-related GI infections with symptoms that include loss of appetite, nausea, vomiting and diarrhea. There is no therapeutic available to treat this condition, and we believe FW-1022 offers the potential to address this serious and possibly long-lasting after-effect of COVID-19.”
Daniel Burch, M.D., Senior Vice President and Global Head of PPD® Biotech, stated, “PPD is pleased to support AzurRx’s efforts to bring relief to patients suffering from COVID-19-related GI infections. We recognize the breakthrough nature of AzurRx’s work with FW-1022 and look forward to applying our capabilities and expertise to the development of FW-1022, beginning with the planned Phase 2 clinical trial.”
I've been with this one for a couple of years, and I've been through two R/S. But I have averaged down, and now I am comfortable with my position.
Yep, finally primed for success.
No, doesn't work that way.
Simply because the ask went up. If it comes back down, you will probably get filled.
And we go higher tomorrow.
No, not at all.
This stock wants to break out, IMO. Soon, quite soon.
I notice that the ask has gotten thinner the past few days.
Looks like we lost the "D" today. I feel so naked.
ELTP is a bit jiggy today. Nice.